产品详情 |
Edit |   |
Product Name | Recombinant Human CCL18/PARC Protein |
Description | Purity >98%, by SDS-PAGE. MW (theoretical): 7.8 kDa. The Recombinant Human CCL18/PARC Protein from Novus Biologicals is derived from E. coli. The Recombinant Human CCL18/PARC Protein has been validated for the following applications: SDS-Page, Bioactivity. |
Size | 10 ug |
Concentration | lyophilized |
Applications | SDS-Page, Bioactivity |
Other Names | Alternative macrophage activation-associated CC chemokine 1, AMAC1CC chemokine ligand 18, AMAC-1Small-inducible cytokine A18, chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated), CKb7, DC-CK1CC chemokine PARC, DCCK1Macrophage inflammatory protein 4, Dendritic cell chemokine 1, MIP4, MIP-4C-C motif chemokine 18, PARCPulmonary and activation-regulated chemokine, SCYA18chemokine (C-C), dendritic, small inducible cytokine A18, small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary andactivation-regulated |
Gene, Accession, CAS # | CCL18, Gene ID: 6362, SwissProt: P55774 |
Catalog # | NBP1-99398-10ug |
Price | |
Order / More Info | Recombinant Human CCL18/PARC Protein from NOVUS BIOLOGICALS, LLC |
Product Specific References | n/a |
产品资料 |
|
|